A Multi-Center Study to Evaluate the Guideline Education of Oncology Departments in Small/Middle Tier Cities and County Hospitals for Diagnosis and Treatment Improvement in Patients With Metastatic Non-small Cell Lung Cancer
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- AstraZeneca
- 入组人数
- 1,000
- 试验地点
- 47
- 主要终点
- To evaluate the molecular testing pattern in metastatic NSCLC patients after QIP
研究概览
简要总结
To evaluate the molecular testing pattern in metastatic NSCLC patients after QIP; To evaluate the treatment pattern in metastatic NSCLC patients after QIP.
详细描述
The primary objective of this study is to assess the implementation of standardized diagnosis and treatment practice in oncology departments of Small/Middle tier cities and County hospitals, after standardized education and implementation of lung cancer clinical practice guidelines for oncology physicians.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥18 years, at the time of signing the informed consent.
- •ECOG performance status 0-
- •Newly pathologic diagnosed metastatic NSCLC (clinical stage IV) or recurrent metastatic NSCLC.
排除标准
- •Be participating in other intervention clinical trials.
- •Judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures, restrictions, and requirements.
- •Previous enrolment in the other QIP study.
结局指标
主要结局
To evaluate the molecular testing pattern in metastatic NSCLC patients after QIP
时间窗: Approximately 1 month after last patient in
Molecular testing-rate for the first-line treatment: Defined as the number of participants received molecular testing for the first-line treatment divided by total participants.
To evaluate the treatment pattern in metastatic NSCLC patients after QIP
时间窗: Approximately 1 month after last patient in
TKIs first-line treatment rate: Defined as TKIs first-line treatment rate in AGA positive participants.
次要结局
- To evaluate the clinical outcomes in metastatic NSCLC patients after QIP(Follow up approximately 24 months after last patient in)
- To evaluate the clinical outcomes in metastatic NSCLC patients after QIP(Follow up approximately 24 months after last patient in)
- To evaluate the treatment pattern in metastatic NSCLC patients after QIP(Approximately 1 month after last patient in)